New study highlights PSA levels in transgender women receiving oestrogen
A recent study published in the Journal of the American Medical Association (JAMA) has shed…
Browsing: Featured
Lifestyle interventions for cancer survivors’ fatigue and sleep disturbances
A comprehensive review published in Maturitas has revealed promising non-pharmaceutical strategies to address two of the…
Childhood cancers not on the rise in SA and NT but disparity remains for Indigenous children
Despite national and global reports of rising incidences of cancer affecting children and young people,…
Algae microrobots deliver doxorubicin directly to lung tumours in mice
Scientists at the University of California San Diego, USA, have developed microrobots capable of delivering…
Looking to nature: Plant research shows promise against cervical cancer cells
Research focused on collecting and analysing plants native to Ethiopia is showing promise against cervical…
Fasting primes the immune system’s natural killer cells to better target cancer, new study in mice finds
Periods of fasting reprogram the immune system’s natural killer cells to better fight cancer, according…
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for adult relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (r/r ALL)
This content is password-protected. To view it, please enter the password below. Password:
Episode 11: On Advocacy and Revolutions: In Conversation with Matthew Zachary
Join Medical Oncologist Professor Bogda Koczwara AM and advocate Matthew Zachary, cancer survivor, founder of Stupid Cancer and the creative force behind the documentary Cancer Mavericks.
ASCO 2024: Promising results from the first clinical trial of an innovative next-generation antibody in patients with advanced solid tumours, especially in melanoma
Initial data from the first phase 1 trial of the bispecific antibody FS222 demonstrate that…
5000 Australians with toughest cancers referred to PrOSPeCT for free comprehensive genomic profiling
The nation’s largest cancer genomics initiative PrOSPeCT (Precision Oncology Screening Platform Enabling Clinical Trials) has…